On Tuesday, May 23, 2017, a number of experts conducted clinical trials, which are of fundamental importance for the evaluation of the efficacy and safety of innovative treatments. On the National Day of Clinical Trials, which took place in the Senate of the Parliament of the Czech Republic in Prague. The issue of rare diseases was also discussed and the patient also shared her experience with clinical trials with participants.
The conference was held on the occasion of the International Day of Clinical Trials. The event was sponsored by the Deputy Chairman of the Committee on Health and Social Policy of the Senate of the Parliament of the Czech Republic and the Director of the Masaryk Institute of Oncology prof. MUDr. Jan Zaloudik, CSc. with professional cooperation of the Czech Clinical Research Infrastructure Network (CZECRIN) and the PharmAround endowment fund.